Novel Natural Product Derivatives Treating Chronic Metabolic and Inflammatory Diseases

Problem

Type 2 diabetes and related metabolic disorders affect hundreds of millions of patients and are frequently accompanied by chronic inflammation, which accelerates disease progression and complications. Existing antidiabetic therapies often fail to adequately address inflammatory pathways and are associated with significant side effects, such as weight gain, cardiovascular risk, or hepatic toxicity. There is a significant unmet need for therapies that simultaneously modulate metabolic dysfunction and inflammation using safer, well‑tolerated mechanisms.

Solution

Researchers at The Ohio State University have developed two complementary classes of small‑molecule derivatives inspired by natural products used in traditional medicine, that address inflammatory and metabolic dysregulation:

  • Glycosylated phenolic derivatives from Hintonia: in vitro studies showed that the lead derivative compound significantly decreased NF‑κB activity, a key driver of chronic inflammation. In vivo testing in Type II diabetes zebrafish model demonstrated hypoglycemic effects and anti‑inflammatory activity
  • Benzofuran derivatives from Myristica: in laboratory experiments, treatment with these derivatives attenuated NF‑κB, and modulated PPAR‑γ, GLUT‑4, and PEPCK, key regulators of glucose metabolism and insulin sensitivity. Preliminary studies in a murine model showed that crude extracts from this plant exhibited hypoglycemic effects. Further testing in a diabetic zebrafish model of both extracts and pure derivatives demonstrated improved glycemic control and reduced inflammatory signaling.

Applications

  • Treatment of Type II diabetes and insulin resistance
  • Management of chronic inflammatory and metabolic disorders
  • Adjunct or combination therapy with existing antidiabetic drugs

Advantages

  • Dual‑action mechanism targeting both metabolic dysfunction and inflammation
  • Modulation of well‑validated pathways (NF‑κB, PPAR‑γ, GLUT‑4, TNKS)
  • High selectivity of targets
  • Potential for fewer off-target drug effects and side effects
  • Optimized from natural products with known dietary exposure history
  • Availability and affordability of compound
  • Broad derivative space enabling further medicinal chemistry optimization

Seeking opportunities for out-licensing and collaboration

Loading icon